APA (7th ed.) Citation

Shimazu, K., Tada, Y., Morinaga, T., Shingyoji, M., Sekine, I., Shimada, H., . . . Tagawa, M. (2017). Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways. BMC Cancer, 17, 1. https://doi.org/10.1186/s12885-017-3300-y

Chicago Style (17th ed.) Citation

Shimazu, Kengo, et al. "Metformin Produces Growth Inhibitory Effects in Combination with Nutlin-3a on Malignant Mesothelioma Through a Cross-talk Between MTOR and P53 Pathways." BMC Cancer 17 (2017): 1. https://doi.org/10.1186/s12885-017-3300-y.

MLA (9th ed.) Citation

Shimazu, Kengo, et al. "Metformin Produces Growth Inhibitory Effects in Combination with Nutlin-3a on Malignant Mesothelioma Through a Cross-talk Between MTOR and P53 Pathways." BMC Cancer, vol. 17, 2017, p. 1, https://doi.org/10.1186/s12885-017-3300-y.